Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Shanghai Zhimeng Biopharma discovers Toll-like receptor 8 agonists

March 16, 2021

NSD3 drives oncogenesis in LUSC, but may sensitize these tumors to bromodomain inhibition

March 15, 2021

IFN-mediated NAD depletion by upregulation of PARP9/10/14 sensitizes PDAC cells to NAMPT inhibitors

March 15, 2021

Galapagos presents TYK2 inhibitors

March 15, 2021

Inflazome synthesizes new NLRP3 inflammasome inhibitors

March 15, 2021

Hunan Warrant Pharmaceuticals patents Bcr-Abl1 and/or BTK inhibitors

March 15, 2021

Targeting membrane protein starves pancreatic tumors

March 15, 2021

Genfleet Therapeutics presents GTPase KRAS mutant inhibitors

March 12, 2021

BeiGene discloses MAP4K1 inhibitors

March 12, 2021

Enrollment opens in phase III trial of [177Lu]PNT-2002 for metastatic CRPC

March 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...